Transcat, Inc. (NASDAQ:TRNS) Director Christopher P. Gillette Sells 456 Shares

Transcat, Inc. (NASDAQ:TRNS - Get Free Report) Director Christopher P. Gillette sold 456 shares of the firm's stock in a transaction dated Tuesday, October 8th. The stock was sold at an average price of $119.95, for a total value of $54,697.20. The sale was disclosed in a filing with the SEC, which is accessible through this link.

Transcat Stock Performance

TRNS traded down $0.09 during trading on Thursday, hitting $89.26. The company's stock had a trading volume of 1,322 shares, compared to its average volume of 106,809. The company has a quick ratio of 1.98, a current ratio of 2.42 and a debt-to-equity ratio of 0.14. The business's 50 day simple moving average is $80.69 and its 200-day simple moving average is $89.38. The firm has a market cap of $830.87 million, a PE ratio of 48.25 and a beta of 0.69. Transcat, Inc. has a one year low of $67.56 and a one year high of $147.12.

Transcat (NASDAQ:TRNS - Get Free Report) last released its quarterly earnings results on Monday, May 19th. The scientific and technical instruments company reported $0.64 earnings per share for the quarter, missing the consensus estimate of $0.66 by ($0.02). Transcat had a net margin of 6.22% and a return on equity of 7.23%. The firm had revenue of $77.13 million for the quarter, compared to analysts' expectations of $76.40 million. The business's revenue was up 8.8% on a year-over-year basis. As a group, sell-side analysts predict that Transcat, Inc. will post 2.3 EPS for the current fiscal year.

Hedge Funds Weigh In On Transcat

A number of hedge funds and other institutional investors have recently made changes to their positions in the company. Centiva Capital LP grew its holdings in Transcat by 6.0% during the fourth quarter. Centiva Capital LP now owns 3,009 shares of the scientific and technical instruments company's stock worth $318,000 after acquiring an additional 171 shares during the period. Bank of New York Mellon Corp raised its position in Transcat by 0.6% in the first quarter. Bank of New York Mellon Corp now owns 27,916 shares of the scientific and technical instruments company's stock valued at $2,078,000 after purchasing an additional 172 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in shares of Transcat by 3.9% during the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 5,137 shares of the scientific and technical instruments company's stock worth $543,000 after purchasing an additional 194 shares during the period. Diamond Hill Capital Management Inc. increased its stake in Transcat by 3.4% during the first quarter. Diamond Hill Capital Management Inc. now owns 6,353 shares of the scientific and technical instruments company's stock worth $473,000 after purchasing an additional 210 shares during the period. Finally, US Bancorp DE grew its stake in Transcat by 14.6% during the 1st quarter. US Bancorp DE now owns 1,770 shares of the scientific and technical instruments company's stock worth $132,000 after purchasing an additional 226 shares in the last quarter. Institutional investors own 98.34% of the company's stock.

Analysts Set New Price Targets

TRNS has been the subject of several research reports. HC Wainwright reissued a "buy" rating and set a $116.00 price target (up from $106.00) on shares of Transcat in a report on Wednesday, May 21st. Wall Street Zen upgraded shares of Transcat from a "sell" rating to a "hold" rating in a research note on Wednesday. Northland Securities reiterated a "market perform" rating and issued a $85.00 price objective (down previously from $110.00) on shares of Transcat in a report on Wednesday, January 29th. Finally, Oppenheimer cut Transcat from an "outperform" rating to a "market perform" rating in a research note on Wednesday, January 29th. Three equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of "Hold" and an average price target of $114.00.

Transcat Company Profile

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.